ZURICH, May 28 (Reuters) - A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday.
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
No comments:
Post a Comment